Free Trial

Oncology Institute (TOI) News Today

Oncology Institute logo
$1.94 +0.04 (+2.11%)
As of 04:00 PM Eastern
The Oncology Institute, Inc. stock logo
Daniel Virnich Buys 22,640 Shares of The Oncology Institute, Inc. (NASDAQ:TOI) Stock
The Oncology Institute, Inc. (NASDAQ:TOI - Get Free Report) CEO Daniel Virnich acquired 22,640 shares of the stock in a transaction dated Wednesday, March 26th. The shares were bought at an average cost of $1.04 per share, with a total value of $23,545.60. Following the completion of the transaction, the chief executive officer now owns 724,363 shares of the company's stock, valued at approximately $753,337.52. This represents a 3.23 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
The Oncology Institute, Inc. stock logo
Insider Buying: The Oncology Institute, Inc. (NASDAQ:TOI) Director Buys 90,562 Shares of Stock
The Oncology Institute, Inc. (NASDAQ:TOI - Get Free Report) Director Mark L. Pacala purchased 90,562 shares of the firm's stock in a transaction on Wednesday, March 26th. The shares were acquired at an average price of $1.04 per share, with a total value of $94,184.48. Following the completion of the acquisition, the director now owns 224,971 shares in the company, valued at approximately $233,969.84. This trade represents a 67.38 % increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Q4 2024 Oncology Institute Inc Earnings Call
The Oncology Institute, Inc. stock logo
Oncology Institute (NASDAQ:TOI) Releases Earnings Results
Oncology Institute (NASDAQ:TOI - Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.14) EPS for the quarter. Oncology Institute had a negative return on equity of 186.83% and a negative net margin of 17.63%.
The Oncology Institute announces $16.5M private placement
The Oncology Institute sees FY25 revenue $460M-$480M
The Oncology Institute reports Q4 EPS (14c) vs. (21c) last year
The Oncology Institute, Inc. stock logo
FreeGulliver LLC Grows Stock Holdings in The Oncology Institute, Inc. (NASDAQ:TOI)
FreeGulliver LLC lifted its stake in The Oncology Institute, Inc. (NASDAQ:TOI - Free Report) by 219.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 600,747 shares of the company's stock after purchasing an additional 412,578 s
The Oncology Institute, Inc. stock logo
Tiff Advisory Services LLC Purchases 346,256 Shares of The Oncology Institute, Inc. (NASDAQ:TOI)
Tiff Advisory Services LLC raised its position in The Oncology Institute, Inc. (NASDAQ:TOI - Free Report) by 13.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,979,141 shares of the company's stock aft
The Oncology Institute, Inc. stock logo
The Oncology Institute, Inc. (NASDAQ:TOI) Short Interest Up 188.3% in February
The Oncology Institute, Inc. (NASDAQ:TOI - Get Free Report) was the target of a large increase in short interest during the month of February. As of February 15th, there was short interest totalling 934,800 shares, an increase of 188.3% from the January 31st total of 324,300 shares. Approximately 2.5% of the shares of the company are short sold. Based on an average daily trading volume, of 1,970,000 shares, the short-interest ratio is presently 0.5 days.
The Oncology Institute announces amendment to facility agreement
The Oncology Institute, Inc. stock logo
Oncology Institute (NASDAQ:TOI) Stock Price Down 6.9% - Time to Sell?
Oncology Institute (NASDAQ:TOI) Trading Down 6.9% - Should You Sell?
The Oncology Institute, Inc. stock logo
Short Interest in The Oncology Institute, Inc. (NASDAQ:TOI) Expands By 86.8%
The Oncology Institute, Inc. (NASDAQ:TOI - Get Free Report) saw a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling 324,100 shares, a growth of 86.8% from the December 31st total of 173,500 shares. Based on an average daily volume of 1,740,000 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.9% of the shares of the company are sold short.
Florida Blue enhances cancer care for thousands of members
Oncology Institute Reports Strong Revenue Growth Amid Challenges
Oncology Institute Delivers a Mixed Q3
Oncology Institute Announces Board Changes for 2025
The Oncology Institute Reports Third Quarter 2024 Financial Results
A Peek at The Oncology Institute's Future Earnings
Remove Ads
Get Oncology Institute News Delivered to You Automatically

Sign up to receive the latest news and ratings for TOI and its competitors with MarketBeat's FREE daily newsletter.

TOI Media Mentions By Week

TOI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TOI
News Sentiment

0.62

0.79

Average
Medical
News Sentiment

TOI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TOI Articles
This Week

2

2

TOI Articles
Average Week

Remove Ads
Get Oncology Institute News Delivered to You Automatically

Sign up to receive the latest news and ratings for TOI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:TOI) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners